Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Morrow

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Research Square|June 12, 2025
Identification of cross-stage, cross-species malaria CD8+ T cell antigensCaroline Junqueira, Camila R R Barbosa Barbosa, Luna de Lacerda, et al.
Nature Reviews. Drug Discovery|January 29, 2022
A call to action for translational sciences in COVID-19 and future pandemicsKanny K Wan, Danielle Davis, Taylor N Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2025
Glycoprotein L-deleted single-cycle rhesus cytomegalovirus vectors elicit MHC-E-restricted CD8+ T cells that protect against SIVScott G Hansen, John B Schell, Emily E Marshall, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Nature Medicine|August 8, 2018
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A Okoye, Scott G Hansen, Mukta Vaidya, et al.
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
F1000Research|February 1, 2024
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impactStefan Jungbluth, William Martin, Monika Slezak, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
American Heart Journal|August 25, 2024
Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North AmericaAmrita Balgobind, Matthew Pierce, Carlos Alviar, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Research Square|June 12, 2025
Identification of cross-stage, cross-species malaria CD8+ T cell antigensCaroline Junqueira, Camila R R Barbosa Barbosa, Luna de Lacerda, et al.
Nature Reviews. Drug Discovery|January 29, 2022
A call to action for translational sciences in COVID-19 and future pandemicsKanny K Wan, Danielle Davis, Taylor N Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2025
Glycoprotein L-deleted single-cycle rhesus cytomegalovirus vectors elicit MHC-E-restricted CD8+ T cells that protect against SIVScott G Hansen, John B Schell, Emily E Marshall, et al.
JCI Insight|February 7, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIVScott G Hansen, Jennie L Womack, Wilma Perez, et al.
Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.
Nature Medicine|August 8, 2018
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A Okoye, Scott G Hansen, Mukta Vaidya, et al.
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
F1000Research|February 1, 2024
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impactStefan Jungbluth, William Martin, Monika Slezak, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
American Heart Journal|August 25, 2024
Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North AmericaAmrita Balgobind, Matthew Pierce, Carlos Alviar, et al.
Pageof 11